Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Perrigo (NYSE: PRGO) said it will release fourth quarter and fiscal year 2025 results on February 26, 2026 and host an earnings call at 8:30 A.M.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Perrigo (NYSE: PRGO) said it will release fourth quarter and fiscal year 2025 results on February 26, 2026 and host an earnings call at 8:30 A.M. ET. The call will be live via webcast and available by phone; a taped replay is provided through March 5, 2026.

Perrigo is a consumer health company with leading OTC brands and directs investors to its SEC filings for risks and additional details.

Argus Feb 13 session

+1.11% close to close Open Argus

Details

News Market Reaction – PRGO

On Feb 13, the day this news came out, PRGO closed 1.11% above the previous close.

Data tracked by StockTitan Argus for the Feb 13 session.

Key Figures

Earnings release date: February 26, 2026 Conference call time: 8:30 A.M. (EST) US dial-in number: 800-836-8184 +5 more

Earnings release date: February 26, 2026; Planned Q4 and FY 2025 results release
Conference call time: 8:30 A.M. (EST); Start time for earnings conference call
US dial-in number: 800-836-8184; Domestic access for live earnings call
International dial-in number: 646-357-8785; International access for live earnings call
Call reference ID: 52719; Reference ID for live call access
Replay start time: 12:00 P.M. (EST) February 26, 2026; Approximate start of taped replay availability
Replay end date: March 5, 2026; Replay available until midnight
Replay access code: 52719#; Access code for replay lines

Historical Context

5 past events · Latest: Nov 05

5 events

Nov 05
Q3 2025 earnings

24h Move

-25.2%

Q3 2025 sales decline, flat EPS, and lowered full-year outlook.
Nov 05
Strategic review

24h Move

-25.2%

Strategic review of infant formula business and prior $240M investment.
Nov 04
Investor conference

24h Move

-1.7%

Participation in Jefferies Miami Consumer Conference investor meetings.
Oct 29
Dividend declaration

24h Move

-1.5%

Announcement of $0.290 per share quarterly dividend and key dates.
Oct 22
Earnings date set

24h Move

-1.3%

Notification of Q3 2025 earnings release and call logistics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

over-the-counter (otc), forward-looking statements, form 10-k

3 terms

over-the-counter (otc) medical

"As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers..."

Over-the-counter (OTC) describes stocks and other securities traded directly between buyers and sellers outside formal exchanges, using brokers, dealers, or electronic networks. For investors it matters because OTC trading often means lower transparency, fewer rules and thinner trading volume—like buying at a small flea market instead of a big supermarket—so prices can swing more and the risk of not being able to sell quickly is higher.

forward-looking statements regulatory

"This press release includes, and the matters discussed... will include certain "forward-looking statements"..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"...including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024."

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/13/2026 - 08:30 AM EST

DUBLIN, Feb. 13, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its fourth quarter and fiscal year 2025 financial results on Thursday, February 26^th, 2026, and host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 52719. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Thursday, February 26, until midnight Thursday, March 5, 2026. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 52719#.

About Perrigo

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Associate Director, Global Investor Relations, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-fourth-quarter-and-fiscal-year-2025-financial-results-on-february-26-2026-302687665.html

SOURCE Perrigo Company plc

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Perrigo (PRGO) release Q4 and fiscal year 2025 financial results?

Perrigo will release its Q4 and fiscal year 2025 financial results on February 26, 2026. According to the company, the announcement will be followed by a conference call beginning at 8:30 A.M. ET and a webcast for investors and analysts.

How can investors join the Perrigo (PRGO) earnings conference call on February 26, 2026?

Investors can join the Perrigo earnings call via live webcast or by phone with the provided dial-in numbers and reference ID. According to the company, the webcast will be available in the investor relations section of Perrigo's website.

When and how can I listen to the Perrigo (PRGO) taped replay of the February 26, 2026 call?

A taped replay will be available beginning about 12:00 P.M. ET on February 26 through midnight March 5, 2026. According to the company, investors can access the replay by phone using the listed access code and international numbers.

What will Perrigo (PRGO) include in the February 26, 2026 earnings release and call?

The earnings release and call will present fourth quarter and full-year 2025 financial results and discussion of performance. According to the company, materials will include forward-looking statements and direct investors to SEC filings for detailed risk disclosures.

Where can I find Perrigo (PRGO) investor materials and SEC filings referenced for the February 26, 2026 results?

Investor materials and SEC filings are available on Perrigo's investor website and SEC filings portal. According to the company, its investor relations site hosts the webcast, press release, and links to Form 10-K and other SEC filings for deeper detail.

Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026